Eli Lilly and Co

Company Snapshot
Lilly Corporate Center
Indianapolis, IN 46285
United States
Sector: Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 47,000
https://www.lilly.com
Please select from the dropdown
  1. Executive Compensation
  2. > Eli Lilly and Co
Company Financials

2022
2023
2024
Gross Profit
$21,911,600,000
$27,041,900,000
$36,624,400,000
Operating Income
$8,280,400,000
$10,787,300,000
$17,501,700,000
Net Income
$6,244,800,000
$5,240,400,000
$10,590,000,000
2022
Gross Profit
$21,911,600,000
Operating Income
$8,280,400,000
Net Income
$6,244,800,000
2023
Gross Profit
$27,041,900,000
Operating Income
$10,787,300,000
Net Income
$5,240,400,000
2024
Gross Profit
$36,624,400,000
Operating Income
$17,501,700,000
Net Income
$10,590,000,000
The above data on Eli Lilly and Co came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Daniel Skovronsky
Executive Vice President Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
$3,739,461
$7,483,400
$631,068
$11,853,929
Daniel Skovronsky
$11,853,929
Executive Vice President Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
Anat Ashkenazi
Executive Vice President and Chief Financial Officer
$2,896,461
$3,689,000
$1,013,796
$7,599,257
Anat Ashkenazi
$7,599,257
Executive Vice President and Chief Financial Officer
Anat Hakim
Executive Vice President General Counsel and Secretary
$2,755,961
$3,952,500
$298,276
$7,006,737
Anat Hakim
$7,006,737
Executive Vice President General Counsel and Secretary
Jacob Van Naarden
Executive Vice President and President, Loxo
$2,334,461
$2,424,200
$127,859
$4,886,520
Jacob Van Naarden
$4,886,520
Executive Vice President and President, Loxo
Karen Walker
Independent Director
$119,000
$200,000
$40,000
$359,000
Karen Walker
$359,000
Independent Director
Eli Lilly and Co listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us